Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysisResearch article Published on 2020-08-012022-10-05 Journal: The Journal of Infection [Category] [DOI] 10.1016/j.jinf.2020.05.052 [Article Type] Research article
Renin-angiotensin system inhibition in COVID-19 patientsPoint of View Published on 2020-06-082022-10-30 Journal: Netherlands Heart Journal [Category] [DOI] 10.1007/s12471-020-01439-5 PMC 바로가기 [Article Type] Point of View
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical TrialsMedicine Published on 2020-05-222022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2020.00248 PMC 바로가기 [Article Type] Medicine
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patientsShort Report Published on 2020-04-062022-10-31 Journal: eLife [Category] [DOI] 10.7554/eLife.57278 PMC 바로가기 [Article Type] Short Report
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension레닌-안지오텐신계 억제제는 고혈압 환자의 임상 결과를 개선합니다.Letter Published on 2020-03-312022-09-06 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2020.1746200 PMC 바로가기 [Article Type] Letter
Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19Review Published on 2020-01-012023-07-05 Journal: Drug discoveries & therapeutics [Category] [DOI] 10.5582/ddt.2020.03064 PMC 바로가기 [Article Type] Review